Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference

Rhea-AI Summary

Astria Therapeutics, Inc. (Nasdaq:ATXS) announces CEO Dr. Jill C. Milne's presentation on STAR-0215 and STAR-0310 at Jefferies London Healthcare Conference. Webcast available at https://wsw.com/webcast/jeff287/atxs/1884032. Archived replay on www.astriatx.com for 30 days.

BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and information on STAR-0215 and STAR-0310 at the Jefferies London Healthcare Conference on Wednesday, November 15, at 10:30am GMT in London, UK.

A webcast of the presentation can be accessed at the following link: https://wsw.com/webcast/jeff287/atxs/1884032. An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.

About Astria Therapeutics:

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Our second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis. Learn more about our company on our website, www.astriatx.com, or follow us on X and Instagram @AstriaTx and on Facebook and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231109732128/en/

Astria:

Investor Relations and Media:

Elizabeth Higgins

investors@astriatx.com

Source: Astria Therapeutics, Inc.

FAQ

What is the company name or ticker symbol mentioned in the press release?

The company mentioned is Astria Therapeutics, Inc. (Nasdaq:ATXS).

What will be presented at the Jefferies London Healthcare Conference?

CEO Dr. Jill C. Milne will present a corporate overview and information on STAR-0215 and STAR-0310.

Where can the webcast of the presentation be accessed?

The webcast can be accessed at https://wsw.com/webcast/jeff287/atxs/1884032.

For how long will the archived replay of the presentation be available?

The archived replay will be available on www.astriatx.com for 30 days following the event.